GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » Total Stockholders Equity

SYK (Stryker) Total Stockholders Equity : $20,930 Mil (As of Mar. 2025)


View and export this data going back to 1988. Start your Free Trial

What is Stryker Total Stockholders Equity?

Stryker's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $20,930 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Stryker's Book Value per Share for the quarter that ended in Mar. 2025 was $54.77. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Stryker's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.80.

Stryker Total Stockholders Equity Historical Data

The historical data trend for Stryker's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Total Stockholders Equity Chart

Stryker Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13,084.00 14,877.00 16,616.00 18,593.00 20,634.00

Stryker Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19,172.00 19,762.00 20,149.00 20,634.00 20,930.00

Stryker  (NYSE:SYK) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Stryker's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(20930-0)/382.165
=54.77

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Stryker's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(2398 + 14383) / 20930
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stryker Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Stryker's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Stryker Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » Total Stockholders Equity
Comparable Companies
BSX MDT ABT EW DXCM STE ZBH PODD PEN GMED XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 TSE:7733 TSE:6869 LSE:SN. ASX:COH MASI
Traded in Other Exchanges
SYK:Mexico 1SYK:Italy 0R2S:UK SYK:Germany SYK:Germany S1YK34:Brazil SYK:Austria
Address
1941 Stryker Way, Portage, MI, USA, 49002
Website
https://www.stryker.com
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.
Executives
Allan C. Golston director 2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Ronda E Stryker director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Kevin Lobo officer: Group Pres., Neurotech & Spine STRYKER, 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
M Kathryn Fink officer: VP, Global Human Resources 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Viju Menon officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Glenn S Boehnlein officer: Vice President, CFO 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher officer: VP, Chief Legal Officer 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Berry William E Jr officer: Vice President, Controller 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Srikant Datar director ICF INTERNATIONAL, INC., 9300 LEE HIGHWAY, FAIRFAX VA 22031
James Andrew Pierce officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio director BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Timothy J Scannell officer: Group President 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Roch Doliveux director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine Ann Owen officer: VP 2825 AIRVIEW BLVD., KALAMAZOO MI 49002